The chemical class of FAM62C Inhibitors represents a group of compounds designed to modulate or inhibit the activity of the FAM62C protein, known for its role in intracellular signaling, membrane trafficking, and lipid interactions due to its multiple functional domains. These inhibitors are diverse, each targeting specific aspects of FAM62C's activity, such as its involvement in calcium signaling, lipid metabolism, or membrane association. Researchers employ a variety of methods to identify these inhibitors, including biochemical assays to study the interaction between the compounds and the protein, cellular assays to observe the impact on FAM62C's cellular functions, and molecular biology techniques to understand the changes in signaling pathways or protein interactions. The development and characterization of FAM62C inhibitors involve a detailed understanding of the protein's structure and functions, ensuring that these molecules effectively target specific activities of FAM62C within the cellular context.
The pursuit of FAM62C inhibitors is a comprehensive process that integrates knowledge from various scientific disciplines. This includes understanding the protein's role in cellular physiology, the pathways it regulates, and how it interacts with other cellular components. By focusing on the domains and related activities of FAM62C, scientists aim to develop inhibitors that can modulate its function precisely. This involves not only the identification of compounds that can bind to FAM62C but also understanding how these interactions affect the protein's activity and the broader cellular processes it influences. The inhibitors might work by altering the protein's ability to bind to lipids, changing its conformation, disrupting its association with other proteins or membranes, or inhibiting its regulatory activities. As research advances, the repertoire of FAM62C inhibitors continues to grow, offering a range of tools for investigating the protein's function and for modulating its activity in various research contexts. Each inhibitor is a testament to the intricate and detailed approach required to modulate protein function, reflecting the ongoing efforts in scientific research to understand and influence the complex machinery of the cell
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
A calcium chelator that binds free calcium ions, reducing calcium levels and affecting ESYT3's calcium-dependent activities. | ||||||
PIK-93 | 593960-11-3 | sc-364588 | 5 mg | $255.00 | ||
Inhibits PI4K, altering phosphoinositide signaling and membrane trafficking, influencing ESYT3 functions. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $199.00 $599.00 | 24 | |
Inhibits neutral sphingomyelinase, affecting lipid signaling and membrane dynamics, impacting ESYT3's role. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits SERCA, disrupting calcium stores and affecting ESYT3's calcium-mediated activities. | ||||||
Carbetocin | 37025-55-1 | sc-504618 | 10 mg | $330.00 | ||
Inhibits intracellular calcium release, reducing calcium signaling and altering ESYT3's calcium-dependent functions. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor, indirectly affecting signaling pathways and protein interactions involving ESYT3. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits dynamin, disrupting vesicular trafficking and membrane dynamics, affecting ESYT3's role. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
Calmodulin antagonist, disrupting calcium signaling pathways and affecting ESYT3 functions. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $48.00 $199.00 | 1 | |
Inhibits ATPases, altering calcium homeostasis and signaling, which can impact ESYT3's activities. | ||||||